Chiltern, a global contract research organisation, has appointed Roger Hunter as vice president of strategic partnerships in the business development function.

Roger Hunter has 25 years of experience in the pharma and biotech industries where his most recent role was VP of operations with a specialty pharma firm. He holds a degree in pharmacology from the University of Aberdeen and is field-based in the US.

“It gives me great pleasure to welcome Roger Hunter as Chiltern’s new VP of strategic partnerships. Roger comes to us with a strong background in both commercial and development functions within Pharma and Biotech. He has a strong understanding of clinical development and a deep appreciation of the impact that we have on our clients,” said Stuart McGuire, VP, global business development.